D-Pencillamine for Wilson's disease available in India once
Months after a reported shortage of the life-saving D-Penicillamine medicine to treat Wilson’s disease, the country's drug regulator claims it has remedied the problem. The regulator says the shortage occurred due to non-availability of the active pharmaceutical ingredient (API)—the raw material used to give the drug its therapeutic effect.

Wilson’s disease is a rare and potentially fatal genetic disorder that causes excessive accumulation of copper in vital organs like the eyes, liver, kidneys and brain.

"As per the available information and response from the patients, there seems to be no shortage of D-Penicillamine Capsules in the country as of now and the issue is resolved," stated Indian Drugs Controller General (DCGI) GN Singh on Friday.

Apart from D-Penicillamine, there is reportedly another drug—Trientine dihydrochloride—that treats the disease, but it is not produced in India.